Meredith Davis

602 citations
8 papers · 410 · h-index 5

Impact in

  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Colorectal Cancer Treatments and Studies
  • Neurology top 10%
    • Neuroblastoma Research and Treatments

Papers in

    • Cancer Immunotherapy and Biomarkers 7
    • CAR-T cell therapy research 4
    • Colorectal Cancer Treatments and Studies 2
    • Microscopic Colitis 2
    • Neuroendocrine Tumor Research Advances 1

Meredith Davis

7 papers receiving 404 citations

Peers

Meredith Davis
Comparison fields: 5 of 33
  • Oncology 341
  • Neurology 112
  • Epidemiology 155
  • Endocrinology, Diabetes and Metabolism 61
  • Immunology 66
Replace Colleen Veloski with:
Colleen Veloski United States
Stephen M. Schreibman United States
Jillian Thompson United States
R Bonacci Italy
Sheetal Shroff United States
Jamie Goldman United States
Natalia Castrejón de Anta Spain
Tsutomu Tatematsu Japan
Martin B. Niederle Austria
Navin Niles Australia
Meredith Davis relative to Colleen Veloski United States Colleen Veloski's profile →
Citations per field
00.5×1.5×2.1×
Colleen Veloski · 1×
Citations per year

Countries citing papers authored by Meredith Davis

Since Specialization
Citations

This map shows the geographic impact of Meredith Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meredith Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meredith Davis more than expected).

Fields of papers citing papers by Meredith Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meredith Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meredith Davis. The network helps show where Meredith Davis may publish in the future.

Co-authors

The 25 scholars most cited alongside Meredith Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Meredith Davis Line = papers co-authored together Meredith Davis links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1 2014215
2 2017114
3 201744
4 201522
5 201610
6 20204
7 20151
8 20170

About Meredith Davis

Meredith Davis is a scholar working on Oncology, Epidemiology, Immunology, Pathology and Forensic Medicine and Reproductive Medicine, having authored 8 papers that have together received 410 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Microscopic Colitis (2 papers), Cancer Genomics and Diagnostics (1 paper), Neuroendocrine Tumor Research Advances (1 paper) and Vitamin D Research Studies (1 paper). The work is most often cited by research in Oncology (341 citations), Neurology (112 citations), Epidemiology (155 citations), Endocrinology, Diabetes and Metabolism (61 citations) and Immunology (66 citations). Meredith Davis has collaborated with scholars based in United States. Frequent co-authors include Patrick A. Ott, F. Stephen Hodi, Anita Giobbie‐Hurder, Le Min, Rona S. Carroll, Ursula B. Kaiser, Jason J. Luke, Nancy Bailey, Romualdo Barroso‐Sousa and Sara M. Tolaney. Their work appears in journals such as Cancer Immunology Research, Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, Gynecologic Oncology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact